- CEO
- Tim Matula
- Full Time Employees
- 5
- Sector
- Healthcare
- Industry
- Medical - Pharmaceuticals
- Address
- 29235 Stephenson Highway Madison Heights MI United States of America 48071
- IPO Date
- Feb 12, 2010
- Business
- Creative Edge Nutrition, Inc. (FITX) develops, manufactures, markets, and sells a portfolio of health-oriented nutraceuticals and dietary supplements focused on active lifestyles and fitness, offering products in categories including weight loss and metabolic enhancement; recovery and well-being; muscle enhancement and stimulation; energy and fitness; and natural wellness lines. Its core branded products comprise MetaBolic Xtreme for weight loss; Hyper-Infusion, a pre-workout powder to boost endurance and strength; Alpha-Drive for post-cycle therapy; Amino Plex as an intra-workout recovery catalyst; Chia Plex for overall health and well-being; Hemp Plex; CentroPlex; Hemp Nutra Tea; and Nutra Coffee additives, available in formats such as tablets, capsules, powders, and science-based formulations targeting weight management, specific nutrition challenges, and performance enhancement. The company provides these offerings to consumer markets in the United States and internationally through direct-to-consumer channels, private labeling, and branded distribution, while also engaging in business acceleration, management, and proprietary marketing strategies for related industries. Founded in 2002 and headquartered at 29235 Stephenson Highway, Suite 206, Madison Heights, Michigan, the company formerly operated as Laufer Bridge Enterprises Inc. before changing its name in April 2012. In recent years, Creative Edge Nutrition has faced regulatory challenges, including Health Canada rejections of partner Cen Biotech's applications and local opposition to operations in Lakeshore, alongside negative publicity from shareholder concerns and media scrutiny over operational issues. Earlier acquisitions include Science Defined Nutrition in 2012 to bolster innovative product development and A-Z-Nutrition.com as its second direct-to-consumer retail supplement deal that year, though no major funding rounds, partnerships, or new launches have been reported in the last 1-2 years amid stagnant financials and a minimal market capitalization.